Surgery-Induced Peritoneal Cancer Cells in Patients Who Have Undergone Curative Gastrectomy for Gastric Cancer
Authors:
- 6 February 2014
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (6) , 1991-1997
Abstract
Some patients who undergo curative gastrectomy with lymph node dissection (LND) for gastric cancer (GC) show subsequent peritoneal metastasis. The source of these metastatic cells remains unclear. Curative gastrectomy with LND was performed in 102 patients with GC. Peritoneal washing was collected before and after gastrectomy. Cytology, reverse transcription-polymerase chain reaction, and cell culture were used to determine the presence of cancer cells. The proliferative potential of tumor cells was evaluated using Ki-67 staining. Tumorigenic capacity was assessed by cell injection into the peritoneal cavity of NOD/ShiJic-scid mice. Peritoneal recurrence-free survival (RFS) and peritoneal recurrence rate (RR) were examined to determine the clinical relevance of detected cancer cells. Of 102 peritoneal washing samples obtained before gastrectomy, 57 showed no CEA or CK20 mRNA amplification. After gastrectomy, CEA or CK20 mRNA was detected in 35 of these 57 samples, and viable cancer cells were identified in 24. The viable cancer cells in all 24 cases showed Ki-67 positivity, indicating proliferative activity. Cultured viable cancer cells generated peritoneal nodules after spilling over the peritoneal cavity in NOD/ShiJic-scid mice in 4 cases. The peritoneal RFS of patients with CEA or CK20 mRNA amplification after gastrectomy was significantly poorer than that of patients with negative amplification (p < .05). The 24 patients with viable cancer cells in the peritoneal cavity after gastrectomy showed higher peritoneal RR than those without them (p = .033). Viable tumorigenic cancer cells spilled into the peritoneal cavity during surgery, indicating that surgery induces peritoneal metastasis.Keywords
This publication has 22 references indexed in Scilit:
- Dissemination of Free Cancer Cells from the Gastric Lumen and from Perigastric Lymphovascular Pedicles during Radical Gastric Cancer SurgeryAnnals of Surgical Oncology, 2011
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Nodal dissection for patients with gastric cancer: a randomised controlled trialThe Lancet Oncology, 2006
- Does the Intraoperative Peritoneal Lavage Cytology Add Prognostic Information in Patients With Potentially Curative Gastric Resection?Journal of Gastrointestinal Surgery, 2006
- Characterization of early gastric cancer and proposal of the optimal therapeutic strategySurgery, 2001
- Recurrence following curative resection for gastric carcinomaBritish Journal of Surgery, 2000
- Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinomaThe American Journal of Surgery, 1999
- Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancerSurgical Oncology, 1992
- Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancerBritish Journal of Surgery, 1990
- FACTORS OF SIGNIFICANCE IN THE PROGNOSIS OF CANCER OF THE STOMACHAnnals of Surgery, 1937